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Abstract
Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is a group of common human birth 
defects with complex etiology. Although genome-wide association studies have successfully 
identified a number of risk loci, these loci only account for about 20% of the heritability of 
orofacial clefts. The “missing” heritability may be found in rare variants, copy number variants, or 
interactions. In this study, we investigated the role of low-frequency variants genotyped in 1995 
cases and 1626 controls on the Illumina HumanCore+Exome chip. We performed two statistical 
tests, Sequence Kernel Association Test (SKAT) and Combined Multivariate and Collapsing 
(CMC) method using two minor allele frequency cutoffs (1% and 5%). We found that a burden of 
low-frequency coding variants in N4BP2, CDSN, PRTG, and AHRR were associated with 
increased risk of NSCL/P. Low-frequency variants in other genes were associated with decreased 
risk of NSCL/P. These results demonstrate that low-frequency variants contribute to the genetic 
etiology of NSCL/P.
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Introduction
Clefts of the lip with or without cleft palate (CL/P) are among the most common human 
birth defects [Leslie and Marazita 2013; Marazita 2012]. Approximately 30% of clefts are 
syndromic and have co-occurring structural or cognitive anomalies and are caused primarily 
by chromosomal anomalies or mutations in single genes [Mossey et al. 2009]. In contrast, 
the remaining 70% of CL/P occur in isolation and are considered nonsyndromic [Mossey et 
al. 2009]. Nonsyndromic CL/P (NSCL/P) has agenetically complex etiology, caused by 
multiple interacting genetic and environmental risk factors. Many approaches have been 
used to identify genetic risk factors for NSCL/P including linkage, candidate gene, and 
genome-wide association studies (GWAS). Independent GWAS in several different 
populations and family types have revealed the significant genetic heterogeneity with at least 
15 genetic loci conferring risk for NSCL/P [Beaty et al. 2010; Birnbaum et al. 2009; Grant 
et al. 2009; Leslie et al. 2016; Mangold et al. 2010; Sun et al. 2015; Wolf et al. 2015]. For 
some of these loci, such as IRF6 and NOG, follow-up studies have identified functional 
variants that may directly influence craniofacial development [Leslie et al. 2015; Rahimov et 
al. 2008].
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Despite these successes in identifying loci associated with NSCL/P, we estimate these 
known loci only account for a small proportion (about 20%) of the heritability in any 
population. GWAS typically focus on single variant analysis of common SNPs (typically 
with minor allele frequency (MAF) >5%). Other analyses not covered in traditional GWAS 
have been proposed to identify the “missing heritability” of complex disease including rare 
variants, copy number variation, and gene × environment and gene × gene interactions. 
Rare-variant studies for NSCL/P have largely been limited to resequencing of single 
candidate genes in small samples [Leslie and Murray 2012]. Although there are many 
compelling private variants [Jezewski et al. 2003; Leslie et al. 2012; Liu et al. 2016], there 
has been only limited support for a burden of rare variants [Al Chawa et al. 2014; Leslie et 
al. 2012; Suzuki et al. 2009]. We previously sequenced thirteen GWAS or candidate loci in 
1,500 case-parent trios and failed to identify a burden of rare variants using several 
annotation categories. However, an agnostic window-based method identified few regions of 
over-transmission of rare variants [Leslie et al. 2015]. To date, the only genome-wide study 
of rare variants has been exome sequencing of 55 distant relative pairs [Bureau et al. 2014]. 
Therefore, a genome-scale examination of rare variants has not been conducted for NSCL/P. 
In this study, we sought to investigate the role of low-frequency coding variants (MAF<1% 
and MAF<5%) by genotyping 1995 cases and 1626 controls on an exome chip array and 
performing gene-based association tests.
Methods
Study Participants
The participants for this study consist of 1995 unrelated cases with NSCL/P and 1626 
unrelated controls selected from a larger set of cases, controls, and families recruited from 
11 countries across North America, Latin America, Asia, and Europe (Table 1) [Leslie et al. 
2016]. Controls had no known history of orofacial clefts (OFCs) nor other craniofacial 
anomalies. Cases included probands from unrelated families and unrelated individuals 
recruited as singleton cases. All sites had local IRB approval as well as approval at the 
University of Iowa or the University of Pittsburgh.
Genotyping
Full details of the genotyping, quality control, and imputation were previously described 
[Leslie et al. 2016]. Briefly, all samples were genotyped for approximately 580,000 SNPs 
using an Illumina HumanCore+Exome chip with custom content. Quality control included 
filters for >2% missing call rate, deviations from Hardy-Weinberg Equilibrium (p<0.0001) 
in participants with genetically confirmed European ancestry, and monomorphic SNPs.
Principal components analysis (PCA) was performed for a subset of unrelated participants 
using a pruned set of 67K SNPs in low linkage disequilibrium to identify the appropriate 
principal components (PCs) of ancestry within these data. The resulting eigenvectors were 
projected onto the remaining set of participants. The resulting PCs strongly tracked global 
recruitment site and self-reported race/ethnicity. Further, though PCs of ancestry represent 
orthogonal information across the total multiethnic sample, individual PCs may be highly 
collinear in specific strata. Therefore, in addition to the PCs generated across all participants, 
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PCs of ancestry were also generated within each continental group (European, Central/South 
American, and Asian) for use in stratified analyses.
SNP Selection
To identify the subset of coding variants, we obtained the genomic coordinates for exons of 
the canonical gene transcripts from the UCSC Genome Browser. All SNPs genotyped on the 
Illumina HumanCore+Exome chip and located within these exons with at least one observed 
minor allele and a maximum minor allele frequency of 5% were considered for statistical 
analyses (totaling 155,361 genotyped variants).
Imputation of sporadic missingness
We imputed sporadic missing genotypes using the IMPUTE2 software and the 1000 
Genomes Project (phase 3 release) as the reference panel. Imputation accuracy was assessed 
by masked variant analysis, demonstrating high quality imputation, with mean concordance 
of 0.995 for SNPs with minor allele frequency (MAF) < 0.05 and 0.960 for SNPs with MAF 
≥ 0.05. The “most-likely” genotypes (i.e. genotypes with the highest probability, Q) were 
selected for statistical analysis if and only if the highest probability was Q > 0.9. Genotypes 
that could not be imputed to this degree of certainty remained missing in the final analysis.
Statistical Analyses
We tested gene-based association for low-frequency variants using two tests implemented in 
RVTESTS [Zhan et al. 2016]. The first, the combined multivariate and collapsing (CMC) 
method, is a burden test that collapses variants into a single score [Li and Leal 2008]. 
Because burden tests make the assumption that all variants in the gene have the same 
direction of effect, we also utilized a second test, the sequence kernel association test 
(SKAT), which can detect sets of variants with opposite effects [Wu et al. 2011]. The first 18 
PCs of ancestry were included in the combined analyses to protect against genomic inflation 
due to population structure. For stratified analyses, we adjusted for the first 5 population-
specific PCs in European and Central/South American samples, and the first 3 PCs in the 
Asian sample. 14,664 genes with at least two variants were included in the analyses. P-
values less-than 3.4 × 10-6 were considered genome-wide significant (i.e. 0.05/14,664) and 
p-values less than 1.0 × 10-4 were considered to be suggestive. For genes showing evidence 
of association, we scrutinized the quality of genotype calling by inspecting clustering in 
allele intensity plots. We performed functional annotation enrichment analysis on genes 
using ToppFun from the ToppGene Suite [Chen et al. 2009] and assessed significance using 
Bonferroni adjusted p-values. For comparison, we also performed analysis from a selected 
list of genes implicated in human OFCs by GWAS or replicated candidate gene studies, OFC 
syndromes, or animal models [Beaty et al. 2016; Dixon et al. 2011; Leslie and Marazita 
2013] (Supplemental Table II).
Results
We performed analyses of low-frequency variants in our multiethnic population and then 
stratified into three ancestry groups: Europeans, Latin Americans, and Asians (Figure 1, 
Supplemental Figures 1-4). Two genes achieved genome-wide significance. Variants in 
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N4BP2 with frequencies less than 5% were associated with NSCL/P in the Latin American 
population (pSKAT.5 = 5.04 × 10-7) (Table II, Supplemental Figure 4). The second, PFAS, 
was associated in all populations combined and in the Latin American subgroup; however, 
the signal was driven by a single common variant that ultimately failed subsequent quality 
control checks. When we repeated the analyses excluding this SNP, there was no evidence 
that PFAS variants are associated with NSCL/P (p=0.28).
We also examined genes with p-values less than 1 × 10-4 as having suggestive evidence of 
association (Table II). In all populations combined, we identified an association with PRTG 
(pCMC.1 = pCMC.5 = 3.48 × 10-5), DSC1 (pCMC.5 = 9.03 × 10-5), and ALDH5A1 (pSKAT.5 = 
6.68 × 10-5). In the European subgroup, we identified associations in CDSN (pCMC.1 = 1.29 
× 10-5), AHRR (pCMC.1 = pCMC.5 = 2.65 × 10-5), and GTPBP3 (pSKAT.5 = 8.62 × 10-5). In 
the Latin American and Asian subgroups, nine and eight suggestive signals were identified, 
respectively (Table II). Among these, several showed consistent results between CMC and 
SKAT analyses including CCDC77 in the Latin American group; and SMIM21, CCDC62, 
and RNU5D in the Asian subgroup.
SKAT and CMC both test groups of SNPs in aggregate, but it is possible that not all of the 
variants are truly contributing to disease. In addition, the aggregated low-frequency variants 
may not increase risk, but rather appear at higher frequencies in controls, suggesting a 
protective effect. Therefore, we examined the frequencies of the coding variants in each gene 
(Supplementary Table I) and performed single variant tests to determine the direction of 
effect and whether the association signal was driven by a minority of the variants considered 
in the analysis. Variants in AHRR, CDSN, N4BP2, and PRTG were found at generally 
higher frequencies in cases compared to controls indicating that low-frequency variants in 
these genes increase risk of NSCL/P. Of these, N4BP2 was significant only in the MAF<5% 
analysis and two variants with MAF>1% appeared to be driving the association. CDSN was 
also notable in that all five variants had higher frequencies in cases than in controls, but no 
single variant dominated the signal. With the exception of ALDH5A1, HEATR8, and 
YEATS2, genes for which the directions of association were unclear, low-frequency variants 
in the remaining 15 genes (i.e., SMIM21, CCDC62, DSC1, etc.) were generally found at 
higher frequencies in controls and therefore appeared to decrease risk for NSCL/P.
We performed functional enrichment analysis on the group of genes surpassing our 
suggestive p-value threshold. We noted that this gene list was not enriched for Gene 
Ontology (GO) terms related to molecular functions or biological processes, nor did the 
genes group into particular pathways. However, two input genes (DSC1 and CDSN) were 
annotated for the cellular component GO term “desmosome”, resulting in a statistical 
enrichment of the term (p = 4.01 × 10-4; Bonferroni adjusted p = 0.02). Interestingly, there 
was a slight enrichment for interactions with CEP120, a centrosomal protein associated with 
Joubert syndrome and other ciliopathies; three input genes were annotated for this 
interaction (YEATS2, KIAA0586, and CCDC7; p = 8.89 × 10-5; Bonferroni adjusted p = 
0.039). There were no enrichments for terms related to disease, gene family, or domain. In 
contrast, when we interrogated a list of 51 genes associated with orofacial clefts in human or 
mouse (Supplemental Table II), enrichment analysis returned annotations including 
“transcription factor”, “development”, “periderm”, and “epithelium”. Because the top genes 
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were not enriched for these terms, we may be uncovering new biological factors underlying 
risk for NSCL/P.
Discussion
Since the inception of GWAS, the common disease-common variant hypothesis has 
dominated the search for risk loci for common diseases [Pritchard and Cox 2002; Reich and 
Lander 2001]. As it became clear that common variants only accounted for a portion of the 
genetic variance, association studies turned to other types of variants and variants with lower 
minor allele frequencies [Manolio et al. 2009]. This study was motivated by the fact that 
multiple GWAS are estimated to account for only 20% of the heritability of NSCL/P. 
Although there are multiple possible study designs and statistical approaches to address a 
rare-variant hypothesis, this study focused on tests of low-frequency coding polymorphisms 
from the Illumina HumanCore+Exome Chip. This approach is limited to known variants, 
whereas study designs based on sequencing allow the inclusion of novel variants, that may 
be private in NSCL/P families. We were unable to identify a large number of genes for 
which low-frequency variants were strongly associated with NSCL/P; only one, N4BP2, 
surpassed our genome-wide significance threshold. We identified larger numbers of genes 
with suggestive evidence of association, particularly within genetically-defined ancestry 
groups. This is likely due to increased informativeness of variants within homogenous 
populations which increases power to detect an association. However, these subgroups are 
smaller, which simultaneously decreases power. This balance of factors that influence 
statistical power is particularly important to consider in rare-variant studies, which are 
notoriously underpowered.
Interestingly, we did not identify associations with known CL/P-risk genes, including those 
previously implicated in rare variant studies (e.g. MSX1, BMP4, GREM1) [Al Chawa et al. 
2014; Leslie and Murray 2012]. One possible reason for this apparent discrepancy is that 
previous resequencing studies focused on novel, private variants not present on commercial 
SNP panels while the present study is focused on low-frequency polymorphisms. Another 
possible reason is that many of the known risk genes are implicated in Mendelian diseases 
that include syndromic forms of OFCs. These genes tend to be evolutionarily constrained, so 
we would not expect to find deleterious coding polymorphisms in these genes. However, as 
OFCs are no longer considered lethal conditions in developed countries, relaxed selection 
may tolerate higher frequencies of deleterious alleles.
We were unable to identify a suitable replication cohort, as none of the existing GWAS 
consortia included the ExomeChip. As a consequence, these results should be viewed as 
preliminary until replicated by independent efforts. However, among our reported associated 
genes, there are several that could plausibly relate to CL/P risk, based on gene function or 
expression patterns. Two such genes are DSC1 and CDSN, which were annotated as being 
part of desmosomes, the intercellular junctions between apposing cells that are essential for 
mammalian development [Garrod and Chidgey 2008]. Desmosomes are composed of the 
proteins plakoglobin, plakophilin, and a desmosomal cadherin (e.g. desmocollin or 
desmoglein). DSC1 encodes one of the three desmocollin proteins found in humans. Its 
expression is confined to stratified epithelia, which includes adult skin and the tongue. In 
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addition, desmosomes include other associated accessory proteins that are necessary for 
adhesive function, such as corneodesmosin (CDSN), expressed in the epidermis, hair 
follicle, and hard palate epithelium [Jonca et al. 2011]. Inactivation of Cdsn in mice causes 
epidermal barrier dysfunction and hair follicle degeneration, resulting in postnatal death 
[Leclerc et al. 2009]. During palatogenesis, palatal shelves must adhere together prior to 
disintegration of the medial edge epithelium and formation of a complete palate; this timing 
coincides with an increase in desmosomes in the medial edge epithelium [Mogass et al. 
2000]. Thus an association between variants in these genes and risk of NSCL/P is 
biologically plausible although the effects of these specific variants are still unknown.
Low-frequency variants in PRTG, N4BP2, and AHRR demonstrated increased risk for 
NSCL/P. Of these genes, a possible role in craniofacial development is only apparent for 
PRTG, which encodes protogenin, an immunoglobulin domain-containing receptor involved 
in survival of rostral cephalic neural crest cells that form osteogenic and chondrogenic cells 
in the developing face. AHRR (aryl hydrocarbon receptor repressor) and N4BP2 (nedd4 
binding protein) do not appear to be strongly expressed in the developing face.
Among the group of genes for which low-frequency variants decreased risk for NSCL/P, 
there are several interesting genes already implicated in disorders with associated 
craniofacial features. EHMT1 (euchromatic histone methytransferase 1) mutations and 
microdeletions cause Kleefstra syndrome in humans, which includes a range of craniofacial 
dysmorphologies among the associated features [Kleefstra et al. 2006]. Similarly, mutations 
in KIAA0586 cause a range of ciliopathies, including Joubert syndrome [Alby et al. 2015; 
Bachmann-Gagescu et al. 2015; Malicdan et al. 2015]. Studies of the mouse and chicken 
homolog, TALPID3, indicate that the craniofacial defects in TALPID3 mutants are due to 
impaired hedgehog signaling [Buxton et al. 2004]. Finally, de novo mutations in POLD1 
(DNA polymerase delta) have been reported in mandibular hypoplasia, deafness, progeroid 
features, and lipodystrophy syndrome (MDPL syndrome) [Weedon et al. 2013]. In each of 
these cases, it appears that deleterious mutations cause craniofacial anomalies as part of 
syndromes. It is not clear what role the low-frequency coding variants have in decreasing 
risk of NSCL/P, if any.
In summary, here we provide evidence that a burden of low-frequency genetic variants in 
N4BP2, CDSN, AHRR, and PRTG increase risk for nonsyndromic NSCL/P; and that low-
frequency variants in other genes appear to reduce risk for NSCL/P. Although many of these 
genes have not previously been implicated in human craniofacial disorders, our findings are 
corroborated by craniofacial expression patterns or previous associations with craniofacial 
syndromes. Additional sequencing of these genes should be performed to identify additional 
risk variants and to replicate these results. Furthermore, as studies of low-frequency variants 
are underpowered, future studies in much larger sample sizes from all ancestry groups are 
needed to detect low-frequency variant associations in other genes. Overall, this study 
demonstrates that low-frequency variants are associated with NSCL/P and may thus 
contribute to some of the missing heritability of this common, complex structural birth 
defect.
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Figure 1. Association results for gene-based tests (CMC) of variants less than 1%
Manhattan plots and QQ plots are shown for the all populations (A), Europeans (B), Asians 
(C), and Latin Americans (D). The grey line shows Bonferroni-corrected genome-wide 
significance (i.e. p<3.4 × 10-6) and the dashed grey line shows the suggestive threshold (i.e. 
p<1 × 10-4).
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Table I
Demographic details of cases and controls
Population Recruitment Site Controls NSCL/P Cases
Denmark 0 46
Hungary 253 105
Europeans Spain 0 33
Turkey 171 172
United States 411 220
Argentina 30 111
Colombia 277 681
Latin American Guatemala 208 102
Puerto Rico 106 84
United States 5 72
China 27 157
Asian India 38 51
Philippines 96 159
Unspecified (included in combined analysis) 4 2
Total 1626 1995
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